Elisabetta Schiaroli

Perugia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort.

Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort.

Journal: The Journal of antimicrobial chemotherapy

Published: March 27, 2025

Tixagevimab/Cilgavimab: Still a Valid Prophylaxis against COVID-19 New Variants?

Tixagevimab/Cilgavimab: Still a Valid Prophylaxis against COVID-19 New Variants?

Journal: Viruses

Published: February 13, 2024

In-label, off-label prescription, efficacy and tolerability of dalbavancin: report from a National Registry.

In-label, off-label prescription, efficacy and tolerability of dalbavancin: report from a National Registry.

Journal: Infection

Published: November 11, 2023

Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH).

Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH).

Journal: Infectious disease reports

Published: September 04, 2023

The hope and hype of ellagic acid and urolithins as ligands of SARS-CoV-2 Nsp5 and inhibitors of viral replication.

The hope and hype of ellagic acid and urolithins as ligands of SARS-CoV-2 Nsp5 and inhibitors of viral replication.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: August 28, 2023

Synergistic Activity of Remdesivir-Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report.

Synergistic Activity of Remdesivir-Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report.

Journal: Viruses

Published: May 31, 2023

Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir.

Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir.

Journal: International journal of molecular sciences

Published: February 14, 2023

Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients.

Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients.

Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Published: February 07, 2023

Nelfinavir: An Old Ally in the COVID-19 Fight?

Nelfinavir: An Old Ally in the COVID-19 Fight?

Journal: Microorganisms

Published: November 23, 2022

Impact of SARS-CoV-2 Omicron variants on serum neutralization in a cohort of healthcare workers vaccinated with BNT162b2.

Impact of SARS-CoV-2 Omicron variants on serum neutralization in a cohort of healthcare workers vaccinated with BNT162b2.

Journal: The Journal of infection

Published: August 08, 2022

The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro.

The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro.

Journal: Microorganisms

Published: June 16, 2022

Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2.

Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2.

Journal: Viruses

Published: May 26, 2022

Showing 1-12 of 54

Last Updated: 09/26/2026